Tomomi Komura , Masayuki Yoshida , Rio Kurihara , Masato Kinoshita , Masaru Yoshida , Yoshikazu Nishikawa
{"title":"戊sacpeococcus戊sacpeococcus戊sacpeococcus戊sacpeococcus戊sacpeococcus戊sacpeococcus戊sacpeococcus戊sacpeococcus戊sacpeococcus戊sacpeococcus戊sacpeococcus戊sacpeococcus戊sacpeo球菌","authors":"Tomomi Komura , Masayuki Yoshida , Rio Kurihara , Masato Kinoshita , Masaru Yoshida , Yoshikazu Nishikawa","doi":"10.1016/j.jff.2025.106869","DOIUrl":null,"url":null,"abstract":"<div><div>In Parkinson's disease (PD), α-synuclein (α-syn) accumulation drives neuropathological progression, establishing it as a potential therapeutic target. Lactic acid bacteria (LAB) provide various health benefits to the host and are expected to offer protective effects on neurological functions through the brain–gut connection, as indicated by animal studies. However, the protective effects of LAB against α-syn are not well understood. We investigated whether LAB feeding could reduce α-syn accumulation and improve mobility in transgenic <em>Caenorhabditis elegans</em>, an invertebrate model organism that expresses human α-syn. Among the nine screened strains, <em>Pediococcus pentosaceus</em> MCRI-640 suppressed α-syn accumulation and the decrease in bending counts, a locomotion index in nematodes. Additionally, feeding <em>P. pentosaceus</em> MCRI-640 to <em>Oryzias latipes</em> (medaka), a vertebrate model organism, alleviated PD-like behavioral defects induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). <em>P. pentosaseus</em> acts as a probiotic against PD, and PD model worms and medaka can be used to screen effective LAB for prevention.</div></div>","PeriodicalId":360,"journal":{"name":"Journal of Functional Foods","volume":"129 ","pages":"Article 106869"},"PeriodicalIF":3.8000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pediococcus pentosaceus decreases α-synuclein accumulation and alleviates parkinsonism in Caenorhabditis elegans and Oryzias latipes\",\"authors\":\"Tomomi Komura , Masayuki Yoshida , Rio Kurihara , Masato Kinoshita , Masaru Yoshida , Yoshikazu Nishikawa\",\"doi\":\"10.1016/j.jff.2025.106869\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>In Parkinson's disease (PD), α-synuclein (α-syn) accumulation drives neuropathological progression, establishing it as a potential therapeutic target. Lactic acid bacteria (LAB) provide various health benefits to the host and are expected to offer protective effects on neurological functions through the brain–gut connection, as indicated by animal studies. However, the protective effects of LAB against α-syn are not well understood. We investigated whether LAB feeding could reduce α-syn accumulation and improve mobility in transgenic <em>Caenorhabditis elegans</em>, an invertebrate model organism that expresses human α-syn. Among the nine screened strains, <em>Pediococcus pentosaceus</em> MCRI-640 suppressed α-syn accumulation and the decrease in bending counts, a locomotion index in nematodes. Additionally, feeding <em>P. pentosaceus</em> MCRI-640 to <em>Oryzias latipes</em> (medaka), a vertebrate model organism, alleviated PD-like behavioral defects induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). <em>P. pentosaseus</em> acts as a probiotic against PD, and PD model worms and medaka can be used to screen effective LAB for prevention.</div></div>\",\"PeriodicalId\":360,\"journal\":{\"name\":\"Journal of Functional Foods\",\"volume\":\"129 \",\"pages\":\"Article 106869\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-05-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Functional Foods\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1756464625002117\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"FOOD SCIENCE & TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Functional Foods","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1756464625002117","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
Pediococcus pentosaceus decreases α-synuclein accumulation and alleviates parkinsonism in Caenorhabditis elegans and Oryzias latipes
In Parkinson's disease (PD), α-synuclein (α-syn) accumulation drives neuropathological progression, establishing it as a potential therapeutic target. Lactic acid bacteria (LAB) provide various health benefits to the host and are expected to offer protective effects on neurological functions through the brain–gut connection, as indicated by animal studies. However, the protective effects of LAB against α-syn are not well understood. We investigated whether LAB feeding could reduce α-syn accumulation and improve mobility in transgenic Caenorhabditis elegans, an invertebrate model organism that expresses human α-syn. Among the nine screened strains, Pediococcus pentosaceus MCRI-640 suppressed α-syn accumulation and the decrease in bending counts, a locomotion index in nematodes. Additionally, feeding P. pentosaceus MCRI-640 to Oryzias latipes (medaka), a vertebrate model organism, alleviated PD-like behavioral defects induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). P. pentosaseus acts as a probiotic against PD, and PD model worms and medaka can be used to screen effective LAB for prevention.
期刊介绍:
Journal of Functional Foods continues with the same aims and scope, editorial team, submission system and rigorous peer review. We give authors the possibility to publish their top-quality papers in a well-established leading journal in the food and nutrition fields. The Journal will keep its rigorous criteria to screen high impact research addressing relevant scientific topics and performed by sound methodologies.
The Journal of Functional Foods aims to bring together the results of fundamental and applied research into healthy foods and biologically active food ingredients.
The Journal is centered in the specific area at the boundaries among food technology, nutrition and health welcoming papers having a good interdisciplinary approach. The Journal will cover the fields of plant bioactives; dietary fibre, probiotics; functional lipids; bioactive peptides; vitamins, minerals and botanicals and other dietary supplements. Nutritional and technological aspects related to the development of functional foods and beverages are of core interest to the journal. Experimental works dealing with food digestion, bioavailability of food bioactives and on the mechanisms by which foods and their components are able to modulate physiological parameters connected with disease prevention are of particular interest as well as those dealing with personalized nutrition and nutritional needs in pathological subjects.